Inovexus

Inovexus

Founded in Paris, Inovexus structures itself as a transatlantic venture firm that blends European seed-stage sourcing with US-based growth capital networks. The firm targets technical founders at the pre-seed and seed stages, primarily across France and broader Western Europe, with a mandate that spans enterprise SaaS, fintech infrastructure, and applied artificial intelligence. The model emphasizes cross-border syndicates, introducing US co-investors into rounds that would traditionally stay local. Inovexus writes first-check equity into B2B software companies and selective digital health plays, often leading or co-leading rounds and reserving capital for follow-on bridge financings. The firm builds concentrated portfolios, taking board seats where possible and connecting portfolio companies to US-based Series A funds through established co-investment relationships. Public record indicates a strategy favoring capital-efficient, revenue-generating startups over speculative deep-tech moonshots. Portfolio companies have historically drawn from Station F and other Parisian founder networks. The firm maintains its primary operations in Paris. While total committed capital remains undisclosed, Inovexus's model relies on a lean partnership structure and syndicate-style deployment rather than large institutional fund closes. The firm's transatlantic posture suggests ties to US limited partners and co-investors, though specific named backers are not public. Its operational tempo includes regular demo days, US roadshows, and bridge-round facilitation for portfolio companies transitioning to Series A. Structurally, Inovexus differentiates by offering a permanent bridge between two historically disconnected venture ecosystems — French early-stage technical founders and US venture growth capital. This geography-arbitrage function, common in theory but rarely executed with dedicated full-time partners, remains the firm's defining organizational thesis. Succession and governance details are not public.